Mayo Clinic Talks

Host: Christopher L. Camp, M.D.

Guest: Christina K. Zorn

“Culture” is a word that gets a lot of attention, and deservedly so! It is often thought of as the lifeblood of an organization. However, many of us don’t think about the fact that “culture” doesn’t just exist at the level of large organizations. Culture exists for smaller groups, teams, families, and even individuals. In today’s episode, we will work to define “culture”, discuss its impact on groups (large and small) and individuals, provide real world examples of the impact of culture, and discuss ways of optimizing culture in both the workplace and at home.

The three big questions we will tackle in this episode are:
1) What exactly is “culture” and why is it so critical to success?

2) How does “culture” impact behavior and outcomes at work and at home?

3) What steps can I take to contribute to a positive culture in the workplace and for my own personal development?

To help us answer these questions, my guest today is Christina K. Zorn, who is the Chief Administrative Officer of Mayo Clinic.

Learn more about The Human Optimization Project: Mayo Clinic Talks: Human Optimization | Mayo Clinic School of Continuous Professional Development

X: @MayoHumanOpProj

Instagram: @Mayo_Human_Op_Prog

Connect with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development

Host: Darryl S. Chutka, M.D. [@chutkaMD]

Guest: Alina M. Allen, M.D., M.S.

Fat deposits in the liver are quite common and many individuals have no idea they have the condition. A minority of those individuals will develop an associated hepatic inflammation. It’s not entirely clear why some progress to this state, although there are some known risk factors. Steatohepatitis is a potentially serious health problem and can lead to end-stage liver disease. It’s also associated with cardiovascular disease and all of its complications. The topic for today’s podcast is Hepatic Inflammation and Metabolic Dysfunction-Associated Steatohepatitis. My guest is Alina M. Allen, M.D., M.S., from the Division of Gastroenterology and Hepatology at the Mayo Clinic. What are the risk factors for this health problem? Should we be screening patients for its presence and how should it be managed. These are just some of the topics we’ll discuss in this podcast.

These talks on Inflammation and Cardiometabolic Disease are sponsored by Novo Nordisk

Learn more about this series HERE

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Brought to you by: Mayo Clinic Talks Podcast

Flu and cold season is an annual concern for people around the world. Specifically in the United States, there are massive disparities in both care and outcomes for communities of color related to both diagnosis and treatment of flu and cold. On this episode of the RISE for Equity podcast, Nusheen Ameenuddin, M.D., M.P.H., joins host Nicole Nfonoyim-Hara to discuss COVID’s impact on cold and flu, protecting our communities, and how we can improve education and access to care for marginalized communities.

“The truth of the matter is genetically, we're all very similar. It's not an issue of race, it's an issue of racism. When we actually step back, people can be like, ‘Oh, that situation was a one-off.’ And when we actually look at the data, it's not a one-off. The fact is, we're not asking the right questions, and we need to look deeper to ensure that we are providing the best possible care, the most objective care, the most patient-centered care, particularly when we see that we're falling short. And, and the numbers don't lie.”

Guest: Nusheen Ameenuddin, M.D., M.P.H., is currently an Assistant Professor and Consultant (tenured staff physician) in the Division of Community Pediatric and Adolescent Medicine, Department of Pediatrics, at the Mayo Clinic, Rochester, MN.

Learn more at https://mcpress.mayoclinic.org/rise-for-equity/

This episode is shared from Mayo Clinic Q&A and was recorded in November, 2021

Guest: Gregory A. Poland, M.D. (@drgregpoland)

Host: Halena M. Gazelka, M.D. (@hmgazelkamd)

Omicron, a new COVID-19 variant of concern, has been detected in all regions of the world, including North America. While research and clinical observations on the new strain are underway, it is not yet known what impact, if any, omicron will have on the immune response, transmissibility, or specific COVID-19 treatments.

The emergence of omicron is a reminder to take important steps to protect yourself against COVID-19.

"The answer is masking and boosters," says Dr. Gregory Poland, head of Mayo Clinic's Vaccine Research Group.

Dr. Poland is encouraged by vaccine booster rates in the U.S. "In a relatively short period of time, about 36% of adults who are eligible have indeed gotten a booster," says Dr. Poland. "There's plenty of vaccine available. So in the strongest possible terms, I would recommend getting that booster."

Adults who are six months past completing their initial Moderna or Pfizer COVID-19 vaccination series are eligible to receive a booster dose, as are adults who are two months past completing their initial dose of the Johnson & Johnson vaccine.

On the Mayo Clinic Q&A podcast, Dr. Poland discusses the omicron variant and COVID-19 boosters, and he answers some listener questions.

AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded May 24, 2021.

To claim credit visit: https://ce.mayo.edu/covid19podcast

Guest: Gregory A. Poland, M.D. (@drgregpoland)

Host: Halena M. Gazelka, M.D. (@hmgazelkamd)

The number of COVID-19 cases, hospitalizations and deaths in the U.S. continues to decline. However, cases of COVID-19 are increasing in younger populations.

"It's becoming a childhood disease," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group. "Children have composed over 16,000 hospitalizations for COVID-19 and about 300 have died."

Meanwhile, each day brings fresh research news, including updates on possible side effects of the COVID-19 vaccines.

"We're collecting information as we go and have data on about 4.5 million people now," says Dr. Poland. "That's larger than we would have for any other vaccine."

In this Mayo Clinic Q&A podcast, Dr. Poland expands on these latest news items and puts the data in perspective. He also discusses vaccination rates, the possibility of mixing and matching vaccines for COVID-19 boosters, vaccination rates, and much more.

AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.